The Cardiac Safety Research Consortium ECG database.

Area of Science:

• Cardiology
• Medical Informatics
• Pharmacology

Background:

• The Cardiac Safety Research Consortium (CSRC) established an ECG database to facilitate research.
• The database contains anonymized, digitized ECGs and descriptive variables from thorough QT studies.
• It includes data from placebo and positive control arms submitted to the US Food and Drug Administration (FDA).

Purpose of the Study:

• To foster research using a comprehensive ECG database.
• To support the development and validation of ECG analysis algorithms.
• To provide a resource for investigating cardiac repolarization and automated ECG measurements.

Main Methods:

• Utilizing anonymized, XML-formatted, digitized ECG data from pharmaceutical sponsors.
• Integrating congenital long-QT syndrome patient data and ambulatory ECGs from THEW.
• Making thorough QT datasets available for unblinded algorithm development and blinded comparative testing.

Main Results:

• The CSRC ECG database provides a valuable resource for cardiac safety research.
• It enables the development and testing of algorithms for repolarization analysis.
• A new project focuses on blinded analysis of automated ECG interval measurements from major manufacturers.

Conclusions:

• The CSRC ECG database is a crucial resource for advancing cardiac safety research and ECG analysis.
• It supports the validation of novel algorithms for identifying drug-induced ECG changes.
• The consortium actively encourages applications for clinical investigation using its data resources.